Related Experiment Video
Updated: Apr 1, 2026
10:30
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
5.8K
Chlorotoxin: Structure, activity, and potential uses in cancer therapy
Paola G Ojeda1, Conan K Wang1, David J Craik1
1Institute for Molecular Bioscience, the University of Queensland, Brisbane, QLD, 4072, Australia.
Biopolymers
|September 30, 2015
Summary
Chlorotoxin, a peptide from scorpion venom, shows promise for cancer treatment. Its tumor-targeting ability aids in surgical imaging and drug delivery, offering broad biomedical applications.
Area of Science:
- Biochemistry
- Pharmacology
- Biotechnology
Background:
- Chlorotoxin is a stable peptide derived from Leiurus quinquestriatus scorpion venom.
- It exhibits preferential binding to tumor cells, making it a candidate for cancer therapeutics.
- Its unique properties suggest diverse applications in biotechnology and biomedicine.
Purpose of the Study:
- To review the structure, activity, and potential applications of chlorotoxin.
- To highlight chlorotoxin's utility as a drug design scaffold for cancer treatment.
- To explore its use in tumor imaging and targeted drug delivery systems.
Main Methods:
- Literature review of existing studies on chlorotoxin.
- Analysis of chlorotoxin's structural and biological properties.
- Evaluation of its efficacy in preclinical cancer models (implied).
Main Results:
- Chlorotoxin demonstrates significant potential for cancer therapy.
- Its tumor-specific binding facilitates visualization during surgery.
- It can serve as a delivery vehicle for anti-cancer drugs.
Conclusions:
- Chlorotoxin is a versatile scaffold with substantial therapeutic potential in oncology.
- Further research into chlorotoxin could lead to novel cancer treatments and diagnostic tools.
- Its applications extend to various biotechnology and biomedical fields beyond cancer therapy.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.4K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.4K
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
3.1K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
3.1K
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.5K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.5K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
01:12Bacterial Toxins
51
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
51